295 related articles for article (PubMed ID: 12756099)
1. Phase 1/2 pilot study of methotrexate-laurocapram topical gel for the treatment of patients with early-stage mycosis fungoides.
Demierre MF; Vachon L; Ho V; Sutton L; Cato A; Leyland-Jones B
Arch Dermatol; 2003 May; 139(5):624-8. PubMed ID: 12756099
[TBL] [Abstract][Full Text] [Related]
2. Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study.
Apisarnthanarax N; Talpur R; Ward S; Ni X; Kim HW; Duvic M
J Am Acad Dermatol; 2004 Apr; 50(4):600-7. PubMed ID: 15034511
[TBL] [Abstract][Full Text] [Related]
3. A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.
Duvic M; Sherman ML; Wood GS; Kuzel TM; Olsen E; Foss F; Laliberté RJ; Ryan JL; Zonno K; Rook AH
J Am Acad Dermatol; 2006 Nov; 55(5):807-13. PubMed ID: 17052486
[TBL] [Abstract][Full Text] [Related]
4. Clinical stage IA (limited patch and plaque) mycosis fungoides. A long-term outcome analysis.
Kim YH; Jensen RA; Watanabe GL; Varghese A; Hoppe RT
Arch Dermatol; 1996 Nov; 132(11):1309-13. PubMed ID: 8915308
[TBL] [Abstract][Full Text] [Related]
5. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma.
Kannangara AP; Levitan D; Fleischer AB
J Dermatolog Treat; 2009; 20(3):169-76. PubMed ID: 19016373
[TBL] [Abstract][Full Text] [Related]
7. A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial.
Elewski BE; Fleischer AB; Pariser DM
Arch Dermatol; 2003 Nov; 139(11):1444-50. PubMed ID: 14623704
[TBL] [Abstract][Full Text] [Related]
8. Tumour stage of mycosis fungoides treated with bleomycin and methotrexate: report from the Scandinavian mycosis fungoides study group.
Groth O; Molin L; Thomsen K
Acta Derm Venereol; 1979; 59(1):59-63. PubMed ID: 84469
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced mycosis fungoides and Sézary syndrome with continuous infusions of methotrexate followed by fluorouracil and leucovorin rescue.
Schappell DL; Alper JC; McDonald CJ
Arch Dermatol; 1995 Mar; 131(3):307-13. PubMed ID: 7887660
[TBL] [Abstract][Full Text] [Related]
10. The treatment of psoriasis vulgaris: 1% topical methotrexate gel.
Eskicirak B; Zemheri E; Cerkezoglu A
Int J Dermatol; 2006 Aug; 45(8):965-9. PubMed ID: 16911386
[TBL] [Abstract][Full Text] [Related]
11. Topical methotrexate therapy for psoriasis.
Weinstein GD; McCullough JL; Olsen E
Arch Dermatol; 1989 Feb; 125(2):227-30. PubMed ID: 2913960
[TBL] [Abstract][Full Text] [Related]
12. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
Chu CY
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
[TBL] [Abstract][Full Text] [Related]
13. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
14. Topical nitrogen mustard in early mycosis fungoides. A 12-year experience.
Zachariae H; Thestrup-Pedersen K; Søgaard H
Acta Derm Venereol; 1985; 65(1):53-8. PubMed ID: 2578706
[TBL] [Abstract][Full Text] [Related]
15. Tacalcitol in the treatment of psoriasis vulgaris: the Spanish experience.
Lecha M; Mirada A; López S; Artés M;
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):414-7. PubMed ID: 15987284
[TBL] [Abstract][Full Text] [Related]
16. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy.
Thiboutot DM; Fleischer AB; Del Rosso JQ; Rich P
J Drugs Dermatol; 2009 Jul; 8(7):639-48. PubMed ID: 19588640
[TBL] [Abstract][Full Text] [Related]
17. Phase II clinical trial of bexarotene gel 1% in psoriasis.
Breneman D; Sheth P; Berger V; Naini V; Stevens V
J Drugs Dermatol; 2007 May; 6(5):501-6. PubMed ID: 17679184
[TBL] [Abstract][Full Text] [Related]
18. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of the safety and efficacy of picolinic acid gel in the treatment of acne vulgaris.
Heffernan MP; Nelson MM; Anadkat MJ
Br J Dermatol; 2007 Mar; 156(3):548-52. PubMed ID: 17300246
[TBL] [Abstract][Full Text] [Related]
20. [Narrow band UVB therapy in early stage mycosis fungoides. A study of 23 patients].
Coronel-Pérez IM; Carrizosa-Esquivel AM; Camacho-Martínez F
Actas Dermosifiliogr; 2007 May; 98(4):259-64. PubMed ID: 17506957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]